Previous close | 47.72 |
Open | 47.18 |
Bid | 47.52 x 0 |
Ask | 47.55 x 0 |
Day's range | 46.90 - 47.88 |
52-week range | 43.49 - 67.66 |
Volume | |
Avg. volume | 624,667 |
Market cap | 53.17B |
Beta (5Y monthly) | 0.49 |
PE ratio (TTM) | 28.02 |
EPS (TTM) | 1.69 |
Earnings date | 28 Jul 2022 - 01 Aug 2022 |
Forward dividend & yield | 0.85 (1.78%) |
Ex-dividend date | 16 Feb 2022 |
1y target est | 65.65 |
MALVERN, Pa., June 28, 2022--Siemens Healthineers and The Ohio State University Wexner Medical Center announced a new alliance, aimed at advancing personalized medicine and improving access to high quality, cost-effective healthcare. Through the five-year strategic partnership, Siemens Healthineers and Varian, a Siemens Healthineers company, will provide comprehensive technology and services that will build on previous successful collaborative projects. The university and medical center will con
DGAP-News: Siemens Healthineers AG / Key word(s): Share Buyback/Share BuybackSiemens Healthineers AG: Publication of a capital market information 27.06.2022 / 21:56 The issuer is solely responsible for the content of this announcement.Disclosure pursuant to Art. 5 para. 1 lit. a) of the Regulation (EU) No. 596/2014 (MAR) in conjunction with Art. 2 para. 1 of the Delegated Regulation (EU) No. 2016/1052The share buyback resolved on 24 June 2022 by the Managing Board of Siemens Healthineers AG (her
TARRYTOWN, N.Y., February 03, 2022--Siemens Healthineers announced today the CLINITEST® Rapid COVID-19 Antigen Self-Test1,2 is now available in the U.S. to self-test for the SARS-CoV-2 virus. The CLINITEST Rapid COVID-19 Antigen Self-Test uses a simple nasal swab to provide accurate COVID-19 test results (including for both the Omicron and Delta variants) in 15 minutes and comes in a five-test-per-box configuration—convenient for families, group, and/or serial testing needs. The test is approved